COP
59
2
VRSK
82
-5
O
30
-3
AVY
51
-2
IRM
39
-3
FOX
59
2
RSG
70
-7
CTSH
63
-2
ZTS
47
-2
QRVO
6
2
BLK
72
2
FLR
50
2
ITW
62
-5
EXR
55
-4
NI
70
-3
TGNA
56
-3
AVGO
30
-5
AAP
44
2
AA
41
3
DE
39
3
COP
59
2
VRSK
82
-5
O
30
-3
AVY
51
-2
IRM
39
-3
FOX
59
2
RSG
70
-7
CTSH
63
-2
ZTS
47
-2
QRVO
6
2
BLK
72
2
FLR
50
2
ITW
62
-5
EXR
55
-4
NI
70
-3
TGNA
56
-3
AVGO
30
-5
AAP
44
2
AA
41
3
DE
39
3
Financhill
Back

FingerMotion 10K Form

Buy
51

FNGR
FingerMotion

Last Price:
1.97
Seasonality Move:
-6.9%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive FNGR News And Ratings

See the #1 stock for the next 7 days that we like better than FNGR

FNGR Financial Statistics

Sales & Book Value

Annual Sales: $35.79M
Cash Flow: $-1.5M
Price / Cash Flow: 0
Annual Sales: $0.19
Price / Book: 10.79

Profitability

EPS (TTM): -0.11000
Net Income (TTM): $-5.7M
Gross Margin: $3.86M
Return on Equity: -47.75%
Return on Assets: -25.19%

FingerMotion Earnings Forecast

Key FingerMotion Financial Ratios

  • The Gross Profit Margin over the past 10 years for FNGR is 10.79%.
  • The Selling, General & Administrative Expenses for FNGR have been equal to 19.30% of Gross Profit Margin.
  • The Research & Development expenses have been 1.95% of Revenue.
  • The Interest Expense is -3.23% of Operating Income.
  • The Net Earning history of FNGR is -10.50% of Total Revenues.
  • Per Share Earnings over the last 10 years have been positive in 4 years.

FingerMotion Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Wireless Telecommunication Services
Sector: Communication Services
Current Symbol: FNGR
Website: fingermotion.com

Debt

Debt-to-Equity Ratio: 0.1
Current Ratio: 1.48
Quick Ratio: 1.1

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

FNGR Technical Analysis vs Fundamental Analysis

Buy
51
FingerMotion (FNGR) is a Buy

Is FingerMotion a Buy or a Sell?

  • FingerMotion stock is rated a Buy
    The current FingerMotion [FNGR] share price is $1.99. The Score for FNGR is 51, which is 2% above its historic median score of 50, and infers lower risk than normal.